RT Journal Article
SR Electronic
T1 678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A769
OP A769
DO 10.1136/jitc-2023-SITC2023.0678
VO 11
IS Suppl 1
A1 Guo, Ye
A1 Li, Zhendong
A1 Hu, Desheng
A1 Qu, Song
A1 Zhu, Youhua
A1 Fang, Meiyu
A1 Chen, Wantao
A1 Sun, Chuanzheng
A1 Jiang, Hao
A1 Zong, Jingfeng
A1 Lin, Jinguan
A1 Wang, Siyang
A1 Wang, Wei
A1 Jin, Chuan
A1 Cao, Guochun
A1 Ge, Minghua
A1 Huang, Xiaoming
A1 Wang, Xudong
A1 Li, Zhiming
A1 Wang, Mo
A1 Luo, Xianming
A1 Wei, Shuanghui
A1 Shen, Yuteng
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A769.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.